menu
    • menu

    Company profile for SpyGlass Pharma

    NEW Drugs in Dev: 1
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SpyGlass Pharma, co-founded by Dr. Malik Y. Kahook, MD, and Glenn Sussman, is dedicated to developing innovative treatments for chronic ophthalmic diseases. The company is built upon technology initially developed at the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine. With a team comprising skilled engineers, scientists, and clinicians, SpyGlass Pharma focuses on creating transformative treatm...
    SpyGlass Pharma, co-founded by Dr. Malik Y. Kahook, MD, and Glenn Sussman, is dedicated to developing innovative treatments for chronic ophthalmic diseases. The company is built upon technology initially developed at the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine. With a team comprising skilled engineers, scientists, and clinicians, SpyGlass Pharma focuses on creating transformative treatment options for patients with ophthalmic diseases. Their primary objective is to achieve long-term drug delivery solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SpyGlass PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    27081 Aliso Creek Rd, Suite 125 Aliso Viejo, CA 92656
    Telephone
    Telephone
    +1 9492846904
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.spyglasspharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/spyglasspharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spyglass Pharma Appoints Mike Pinder As Vice President, Marketing
    Spyglass Pharma Appoints Mike Pinder As Vice President, Marketing

    02 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/02/3305080/0/en/spyglass-pharma-appoints-mike-pinder-as-vice-president-marketing.html

    GLOBENEWSWIRE
    02 Jun 2026
    Share Share
    Spyglass Pharma To Participate In Upcoming Investor Conferences
    Spyglass Pharma To Participate In Upcoming Investor Conferences

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299275/0/en/spyglass-pharma-to-participate-in-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    SpyGlass Pharma Gets New CPT Category III Code for BIM-IOL
    SpyGlass Pharma Gets New CPT Category III Code for BIM-IOL

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3296580/0/en/spyglass-pharma-announces-new-add-on-category-iii-cpt-code-for-its-innovative-bim-iol-system.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    SpyGlass Pharma Reports Q1 2026 Financial Results
    SpyGlass Pharma Reports Q1 2026 Financial Results

    14 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/14/3295330/0/en/spyglass-pharma-reports-first-quarter-2026-financial-results-and-provides-corporate-updates.html

    GLOBENEWSWIRE
    14 May 2026
    Share Share
    Spyglass Pharma Reports Q4, Full-Year 2025 Earnings Update
    Spyglass Pharma Reports Q4, Full-Year 2025 Earnings Update

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263396/0/en/SpyGlass-Pharma-Reports-Fourth-Quarter-and-Full-Year-2025-Earnings-and-Provides-a-Corporate-Update.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Spyglass Pharma Reports Successful 12-Month Phase 1/2 Trial
    Spyglass Pharma Reports Successful 12-Month Phase 1/2 Trial

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251760/0/en/SpyGlass-Pharma-Announces-Positive-Topline-12-Month-Phase-1-2-Trial-Results-for-Its-Innovative-BIM-IOL-System.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search